Regional disparities in clinicopathological characteristics and overall survival after radical nephroureterectomy for upper tract urothelial carcinoma: a multi-institutional cohort study across European and Taiwanese centers

BACKGROUND AND OBJECTIVES: Upper tract urothelial carcinoma (UTUC) shows marked geographic variation, partly driven by differences in carcinogenic exposures such as smoking and region-specific environmental toxins. These factors may influence tumour characteristics and outcomes. We assessed whether clinicopathologic features and survival differ between patients treated with radical nephroureterectomy (RNU) at European and Taiwanese centres. METHODS: Data from patients who underwent RNU at 29 centres across Europe and Taiwan were collected. Variable selection for multivariable analysis was performed via LASSO, followed by an adjusted Cox proportional hazards model to identify independent predictors of overall survival (OS). One-to-one propensity score matching (PSM) was applied to balance confounders prior to Kaplan-Meier and restricted mean survival time analyses. KEY FINDINGS AND LIMITATIONS: A total of 2634 patients were included (European: n=2036; Taiwanese: n=598). Taiwanese patients were more often female, had better ECOG performance status, were more frequently never-smokers, had lower clinical T stage, smaller tumours, and more frequently low-grade disease. Treatment patterns also differed, with higher rates of lymphadenectomy and adjuvant chemotherapy in Taiwan, less frequent lymphadenectomy in Europe, and higher positive surgical margin rates in Taiwan. In multivariable analysis, region was not independently associated with OS (HR 1.16, 95% CI 0.95-1.41; p=0.15). Independent predictors of worse OS included older age, worse ECOG, advanced pT stage, nodal involvement, and lymphovascular invasion. OS remained comparable between groups after PSM. CONCLUSION AND CLINICAL IMPLICATIONS: Despite substantial differences in baseline patient characteristics and treatment patterns, geographic region was not independently associated with OS. Outcomes after RNU appear to be primarily determined by established patient- and tumour-level prognostic factors rather than by geographic origin per se. In this study, we compared patients with upper tract urothelial carcinoma treated in Europe and Taiwan. Although patients in Taiwan had smaller tumours and were generally in better overall health, survival outcomes were similar among comparable patients. These findings suggest that prognosis is driven more by individual patient and tumour characteristics than by geographic differences.

Authors

Institutions

Publication Details

Journal
World Journal of Urology
Published
2026-11-17
DOI
https://doi.org/10.1007/s00345-026-06867-3
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Regional disparities in clinicopathological characteristics and overall survival after radical nephroureterectomy for upper tract urothelial carcinoma: a multi-institutional cohort study across European and Taiwanese centers

Bartłomiej Tomasik, Francesco Soria, Navid Roessler, David D‘Andrea et al.
6 links
World Journal of Urology
Bladder and Urothelial Cancer Treatments
article

Regional disparities in clinicopathological characteristics and overall survival after radical nephroureterectomy for upper tract urothelial carcinoma: a multi-institutional cohort study across European and Taiwanese centers

Bartłomiej Tomasik, Francesco Soria, Navid Roessler, David D‘Andrea, Paolo Gontero, Benjamin Pradère, James MO N'Dow, Yao‐Chou Tsai, Matteo Ferro, Shahrokh F. Shariat, Marcin Miszczyk, Chin-Chin Yu, For the PARALLAX-EAU working group
article en

Abstract

BACKGROUND AND OBJECTIVES: Upper tract urothelial carcinoma (UTUC) shows marked geographic variation, partly driven by differences in carcinogenic exposures such as smoking and region-specific environmental toxins. These factors may influence tumour characteristics and outcomes. We assessed whether clinicopathologic features and survival differ between patients treated with radical nephroureterectomy (RNU) at European and Taiwanese centres. METHODS: Data from patients who underwent RNU at 29 centres across Europe and Taiwan were collected. Variable selection for multivariable analysis was performed via LASSO, followed by an adjusted Cox proportional hazards model to identify independent predictors of overall survival (OS). One-to-one propensity score matching (PSM) was applied to balance confounders prior to Kaplan-Meier and restricted mean survival time analyses. KEY FINDINGS AND LIMITATIONS: A total of 2634 patients were included (European: n=2036; Taiwanese: n=598). Taiwanese patients were more often female, had better ECOG performance status, were more frequently never-smokers, had lower clinical T stage, smaller tumours, and more frequently low-grade disease. Treatment patterns also differed, with higher rates of lymphadenectomy and adjuvant chemotherapy in Taiwan, less frequent lymphadenectomy in Europe, and higher positive surgical margin rates in Taiwan. In multivariable analysis, region was not independently associated with OS (HR 1.16, 95% CI 0.95-1.41; p=0.15). Independent predictors of worse OS included older age, worse ECOG, advanced pT stage, nodal involvement, and lymphovascular invasion. OS remained comparable between groups after PSM. CONCLUSION AND CLINICAL IMPLICATIONS: Despite substantial differences in baseline patient characteristics and treatment patterns, geographic region was not independently associated with OS. Outcomes after RNU appear to be primarily determined by established patient- and tumour-level prognostic factors rather than by geographic origin per se. In this study, we compared patients with upper tract urothelial carcinoma treated in Europe and Taiwan. Although patients in Taiwan had smaller tumours and were generally in better overall health, survival outcomes were similar among comparable patients. These findings suggest that prognosis is driven more by individual patient and tumour characteristics than by geographic differences.

World Journal of UrologyVol. 44(1)
Al-Ahliyya Amman University (JO), Sechenov University (RU), University of Milan (IT), Tzu Chi University (TW), University of Aberdeen (GB), Al-Turath University (IQ), Taipei Medical University Hospital (TW), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Comprehensive Cancer Center Vienna (AT), Taipei Tzu Chi Hospital (TW), University Medical Center Hamburg-Eppendorf (DE), WSB University (PL), Weill Cornell Medicine (US), Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo (IT), Taipei Medical University (TW), University of Turin (IT), Gdańsk Medical University (PL), Medical University of Vienna (AT), The University of Texas Southwestern Medical Center (US)
European Association of Urology, Medizinische Universität Wien
Good health and well-being
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon